Jérôme Kluza Selected Research

Jérôme Kluza Research Topics

8	Leukemia 03/2006 - 04/2002
6	Neoplasms (Cancer) 01/2022 - 04/2002
4	Melanoma (Melanoma, Malignant) 01/2014 - 04/2002
2	Leukemia P388 03/2006 - 05/2004
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2021
1	Type 2 Diabetes Mellitus (MODY) 07/2015
1	Prostatic Neoplasms (Prostate Cancer) 04/2005
1	Colonic Neoplasms (Colon Cancer) 09/2004
1	Adenocarcinoma 09/2004
1	Cardiotoxicity 09/2004
1	Breast Neoplasms (Breast Cancer) 09/2004
1	Experimental Melanoma 04/2002

4	AlkaloidsIBA 03/2006 - 12/2003
4	DNA (Deoxyribonucleic Acid)IBA 02/2006 - 12/2003
3	Antineoplastic Agents (Antineoplastics)IBA 03/2006 - 04/2002
2	lamellarin DIBA 03/2006 - 04/2005
2	PoisonsIBA 03/2006 - 04/2005
2	Type I DNA Topoisomerases (Topoisomerase I)IBA 03/2006 - 04/2005
2	CamptothecinIBA 03/2006 - 04/2005
2	Pharmaceutical PreparationsIBA 02/2006 - 09/2004
2	sampangineIBA 11/2005 - 12/2003
2	Antimalarials (Antimalarial Agents)IBA 11/2005 - 12/2003
1	Protein Kinases (Protein Kinase)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	venetoclaxIBA 11/2021
1	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2021
1	Glucose (Dextrose)FDA LinkGeneric 07/2015
1	Glucagon-Like Peptide 1 (GLP 1)IBA 07/2015
1	GoldIBA 01/2014
1	PM031379IBA 03/2006
1	tafluposideIBA 02/2006
1	Etoposide (VP 16)FDA LinkGeneric 02/2006
1	Podophyllotoxin (Condylox)FDA LinkGeneric 02/2006
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2005
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 04/2005
1	lipoarabinomannan (LAM)IBA 04/2005
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2004
1	Fluorescent Dyes (Fluorescent Probes)IBA 09/2004
1	Mitoxantrone (Novantrone)FDA LinkGeneric 09/2004
1	PeroxidesIBA 09/2004
1	AnthracyclinesIBA 09/2004
1	CaspasesIBA 09/2004
1	AnthraquinonesIBA 09/2004
1	ascidideminIBA 12/2003
1	burasaineIBA 12/2003
1	Acronine (Acronycine)IBA 04/2002
1	S 23906-1IBA 04/2002

1	Therapeutics 11/2021
1	Aftercare (After-Treatment) 12/2003